PROTHENA CORPORATION PUBLIC LIMITED COMPANY Gain (Loss) on Disposition of Assets
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-26.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2021-02-26
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY gain (loss) on disposition of assets for the quarter ending 2019-12-31 was $0.00.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY gain (loss) on disposition of assets for the quarter ending 2019-09-30 was $0.00.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY gain (loss) on disposition of assets for the quarter ending 2018-12-31 was -$483.00K.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY gain (loss) on disposition of assets for the quarter ending 2018-09-30 was $0.00.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY gain (loss) on disposition of assets for fiscal 2020 was $0.00.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY gain (loss) on disposition of assets for fiscal 2019 was $0.00.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY gain (loss) on disposition of assets for fiscal 2018 was -$584.00K, a 11780.00% decline from fiscal 2017.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY gain (loss) on disposition of assets for fiscal 2017 was $5.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-26 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $0.00 10-K · filed 2021-02-26 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 10-Q · filed 2019-11-05 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-06 | |||
| 2018-12-31 | -$483.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$483.00K derived: sum of 2 quarters · filed 2021-02-26 | -$584.00K 10-K · filed 2021-02-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$101.00K 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | -$101.00K 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $0.00 derived: sum of 2 quarters · filed 2020-03-03 | $5.00K 10-K · filed 2020-03-03 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $5.00K 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $5.00K 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $0.00 10-K · filed 2019-03-15 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | |||
| 2015-12-31 | -$20.00K 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $19.00K derived: sum of 2 quarters · filed 2017-02-27 | $19.00K 10-K · filed 2017-02-27 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $0.00 10-Q · filed 2014-11-04 | ||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-05 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $29.00K 10-K · filed 2016-02-25 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $29.00K 10-Q · filed 2014-11-04 | ||
| 2013-06-30 | $29.00K 10-Q · filed 2014-08-05 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $0.00 10-K · filed 2015-03-13 | ||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-12 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |